Gosset General Inception General Information
General Inception acts as an "igniter" or business co-founder for deep tech and life science startups. It partners with scientific founders at inception to provide domain expertise, executive talent, infrastructure resources, capital support and access to strategic partners. Its unique model accelerates the journey from idea through seed investment and beyond. With over 35 co-founded ventures since its founding in 2020—including therapeutics platforms leveraging AI-driven biological data analysis—GI has become a key player in building innovative biotech firms targeting major unmet needs in oncology, autoimmune disease and rare disorders. The recent acquisition of Enable Medicine adds advanced generative AI capabilities for drug discovery across the entire ecosystem.
Contact Information
United States
Drug Pipeline
No pipeline data available
Key Partnerships
MD Anderson Cancer Center, Genoa Ventures, Hughes Ventures, Northpond Ventures, OMX Ventures, Paladin Capital Group, Vertical Venture Partners
General Inception Funding
No funding data available